Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 28694273.
- Also identified by DOI 10.1370/afm.2099 and PMC identifier 5505456.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Opioid use disorder is a serious public health problem. Management with buprenorphine is an effective, office-based, medication-assisted treatment, but 60.1% of rural counties in the United States lack a physician with a Drug Enforcement Agency waiver to prescribe buprenorphine. This national study surveyed all rural physicians who have received a waiver in the United States and found that those who were not actively prescribing buprenorphine reported significantly more barriers than those who were, regardless of whether they were treating the maximum number of patients their waiver allowed. These findings suggest the need for tailored strategies to address barriers to providing buprenorphine for opioid use disorder and to support physicians who are adding or maintaining this service.
Medical subject headings
- Buprenorphine
- Drug Prescriptions
- Opioid-Related Disorders
- Practice Patterns, Physicians'
- Rural Health Services